Current Headlines

  1. Accelovance Addresses CRA Shortage With Accelovance Academy Inaugural Graduation Class

    Accelovance, Inc. (Accelovance), a global contract research organization (CRO) focusing in vaccines, oncology, and general medicine clinical research held a graduation ceremony yesterday for Accelovance Academy's inaugural class of Clinical Research Associates (CRAs).

  2. Finesse SmartFactory Platform Featured New Manufacturing And Lab Facility In Iceland

    The first installation of Finesse’s new SmartFactory platform was featured when Alvotech announced the opening of its state-of-the-art manufacturing and lab facility in Reykjavik, Iceland.

  3. VWR Acquires JM Separations

    VWR (NASDAQ: VWR), the leading, global, independent provider of laboratory products, services and solutions, announced today that it has acquired JM Separations, B.V., a supplier of single-use fluid handling and separation technology products for pharmaceutical and biotech customers.

  4. FDA Grants Orphan Drug Designation To SUBA

    HedgePath Pharmaceuticals, Inc. (OTCQB: HPPI), a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today that it has received notice of Orphan Drug Designation for treatment of patients with Basal Cell Carcinoma Nevus Syndrome (BCCNS) with its oral formulation of SUBA-Itraconazole Capsules.

  5. Astellas And Medivation Initiate Phase III Breast Cancer Trial

    Astellas Pharma Inc. (TSE: 4503) and Medivation, Inc. (NASDAQ:MDVN) today announced plans to commence a Phase III clinical trial to investigate the use of enzalutamide for the treatment of triple-negative breast cancer (TNBC).

  6. Phillips-Medisize Acquires Medicom

    Phillips-Medisize Corporation (the “Company”) recently announced that it has acquired Medicom Innovation Partner (“Medicom”), a leading provider of device strategy, product design and development services with particular focus on personal connected health drug delivery device solutions to meet the needs of the rapidly growing biopharma and specialty pharmaceutical markets. Terms of the transaction were not disclosed.

  7. WuXi Biologics And Sartorius Stedim Biotech Open Joint Laboratory In Shanghai

    Sartorius Stedim Biotech, an international leading supplier for the biopharmaceutical industry, and WuXi Biologics recently announced the opening of their Joint Laboratory in Shanghai, marking an exciting new stage in their long-term cooperation.

  8. Webinar: 'Is Standardization Possible In A Custom Single-Use World?'

    Biopharmaceutical manufacturers will gain a greater understanding of how standardization in single-use can streamline and speed-up their projects, thanks to a free webinar to be held next month.

  9. Eppendorf Expands Single-Use Vessel Portfolio For Microbial Fermentation

    Eppendorf expands its portfolio of rigid-wall single-use vessels for fermentation. The newly launched Eppendorf BioBLU 3f was developed specifically for microbial bioprocessing in working volumes of 1.25 to 3.75 L, extending the full range of operation for single-use fermentation from 60 mL to 3.75 L.

  10. Phillips-Medisize Corp. Appoints Richard Even As GM Of Medical Campus In Menomonie Wisconsin

    Phillips-Medisize Corporation recently announced the appointment of Richard Even as General Manager of BioPharma and the medical campus in Menomonie Wisconsin. This is the latest in a series of strategic hires driven by the company’s continued growth in biopharma drug delivery devices, consumable diagnostics, and medical devices.